Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CARIBOU BIOSCIENCES, INC. (CRBU)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

(30% Negative) CARIBOU BIOSCIENCES, INC. (CRBU) Reports Q2 2026 Financial Results

Comment Full text

BEAUTY HEALTH CO (SKIN)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

(99% Positive) BEAUTY HEALTH CO (SKIN) Reports Q2 2026 Financial Results

Comment Full text

ZYMEWORKS INC. (ZYME)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

(10% Negative) ZYMEWORKS INC. (ZYME) Reports Q2 2026 Financial Results

Comment Full text

SPORTRADAR GROUP AG (SRAD)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

Director Koerl Carsten 🟢 acquired 157.8K shares of Sportradar Group AG (SRAD) at $13.49 ($2.1M) Transaction Date: May 06, 2026 | Filing ID: 057135

Comment Full text

DROPBOX, INC. (DBX)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

(75% Positive) DROPBOX, INC. (DBX) Reports Q2 2026 Financial Results

Comment Full text

SILVACO GROUP, INC. (SVCO)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

(30% Negative) SILVACO GROUP, INC. (SVCO) Reports Q2 2026 Financial Results

Comment Full text

SERVE ROBOTICS INC. /DE/ (SERV)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

(30% Negative) SERVE ROBOTICS INC. /DE/ (SERV) Reports Q2 2026 Financial Results

Comment Full text

REPUBLIC SERVICES, INC. (RSG)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

(30% Negative) REPUBLIC SERVICES, INC. (RSG) Reports Q2 2026 Financial Results

Comment Full text

GRAND CANYON EDUCATION, INC. (LOPE)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 3
  • 1 comments

MUELLER BRIAN E 🔴 sold 300 shares of Grand Canyon Education, Inc. (LOPE) Transaction Date: May 05, 2026 | Filing ID: 000006

Comment Full text

GUARDANT HEALTH, INC. (GH)

  • SEC News
  • May 07, 2026, 20:10 UTC
  • 2
  • 1 comments

(30% Negative) GUARDANT HEALTH, INC. (GH) Reports Q2 2026 Financial Results

Comment Full text
  • Previous
  • 307
  • 308
  • 309
  • 310
  • 311
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158458)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin